Clinical profile and outcome of diabetic foot ulcers

D. Boopathy; P. K. Asokan; T. R. Yeshwanth

doi:10.18203/2320-6012.ijrms20231314

Authors

D. Boopathy Department of Surgery, Sri Venkateshwaraa Medical College and Hospital, Redhills, Chennai, Tamil Nadu, India
P. K. Asokan Department of Surgery, Ponneri Government Hospital, Chennai, Tamil Nadu, India
T. R. Yeshwanth Department of Surgery, Sri Venkateshwaraa Medical College and Hospital, Redhills, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20231314

Keywords:

Diabetes, Foot ulcer, Clinical profile

Abstract

Background: Diabetes mellitus is a common metabolic endocrine disorder, once prevalent in developed countries has become the leading ‘global epidemic’. WHO estimated that in the year 2000. Roughly 3% of the total world population had Diabetes. In India around 61million of general population affected in 2011 which may rise to 101 million by 2030. The aim of the study was to study the clinical profile and outcome of diabetic foot ulcers. The clinical profile of 120 patients with diabetic foot ulcer was studied.

Methods: Patients with diabetic foot ulcer of both genders with age above 30 years willing to participate were included in the study. All patients were subjected to routine diabetic work up with Doppler study and X-ray foot to rule out bone involvement.

Results: The majority of patients with diabetic foot ulcers were of age group 51 to 60 years, male predominant, 84 patients out of 120 isolated included for study, 24 (28.6%) isolates had Klebsiella, 46(54.8%) isolates Pseudomonas, 14 (16.7%) isolates has E.coli.

Conclusions: Our study gives important information that diabetic foot ulcer is more common among middle-aged people with male predominance which gives the importance of screening diabetic patients for neuropathy and peripheral vascular disease.

Metrics

Metrics Loading ...

References

Brownrigg JR, Apelqvist J, Bakker K, Schaper NC, Hinchliffe RJ. Evidence-based management of PAD and the diabetic foot. Eur J Vasc Endovasc Surg. 2013;45(6):673-81.

Richmond NA, Maderal AD, Vivas AC. Evidence-based management of common chronic lower extremity ulcers. Dermatol Ther. 2013;26(3):187-96.

CADTH Rapid Response Reports. Optimal Care of Chronic, Non-Healing, Lower Extremity Wounds: A Review of Clinical Evidence and Guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2013.

Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-28.

Reiber GE, Vileikyte L, Boyko EJ, Aguila M, Smith DG, Lavery LA, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22(1):157-62.

Rao N, Lipsky BA. Optimising antimicrobial therapy in diabetic foot infections. Drugs. 2007;67(2):195-214.

Hamano K, Nakadaira I, Suzuki J, Gonai M. N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes. Vasc Health Risk Manag. 2014;10:585-9.

Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ, International Working Group on the Diabetic Foot. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev. 2016;32 (1):2-6.

Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-28.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.

WHO. Defination, diagnosis and classification of diabetes mellitus and its complication: Report of consultation, Report 250. Geneva: WHO; 1999.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.

Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2(2):64-122.

Powers AC. Diabetes mellitus. Harrison’s Principles of Internal Med. 16th ed. New York, NY: McGraw Hill; 2005: 2168-2170.

International Diabetes Federation. Time to Act: Diabetes and foot care. Brussels: International Diabetes Federation; 2005.

Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med. 2004;351(1):48-55.

Chakrabarti A, Ghosh A, Batra R, Kaushal A, Roy P, Singh H. Antifungal susceptibility pattern of non-albicans Candida species & distribution of species isolated from Candidaemia cases over a 5 year period. Indian J Med Res. 1996;104:171-6.

Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag. 2007;3(1):65-76.

Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-28.

Vijay V, Narasimham DV, Seena R, Snehalatha C, Ramachandran A. Clinical profile of diabetic foot infections in south India--a retrospective study. Diabet Med. 2000;17(3):215-8.

Ramakant P, Verma AK, Misra R, Prasad KN, Chand G, Mishra A, et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose? Diabetologia. 2011;54(1):58-64.

Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol. 2008;51(2):204-8.

Tiwari S, Pratyush DD, Dwivedi A, Gupta SK, Rai M, Singh SK. Microbiological and clinical characteristics of diabetic foot infections in northern India. J Infect Dev Ctries. 2012;6(4):329-32.

Dinh T, Veves A. The influence of gender as a risk factor in diabetic foot ulceration. Wounds. 2008;20(5):127-31.

Deribe B, Woldemichael K, Nemera G. Prevalence and Factors Influencing Diabetic Foot Ulcer among Diabetic Patients Attending Arbaminch Hospital, South Ethiopia. J Diabetes Metab. 2014;2:322.

Amareswari VH, Padma K, Dharmarajan P, Shivakumar S, Dhilip KS. Evaluation of Efficacy of Pulsed Electromagnetic Field Therapy as an Adjuvant Therapy in Healing of Diabetic Foot Ulcers. Int J Physiol. 2020;8(2).

Seth A, Attri AK, Kataria H, Kochhar S, Seth SA, Gautam N. Clinical Profile and Outcome in Patients of Diabetic Foot Infection. Int J Appl Basic Med Res. 2019;9(1):14-9.

Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006;29(8):1727-32.

Mottola C, Matias CS, Mendes JJ, Melo-Cristino J, Tavares L, Cavaco-Silva P, et al. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections. BMC Microbiol. 2016;16(1):119.

Zubair M, Malik A, Ahmad J. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital. Foot (Edinb). 2012;22(1):24-30.

Roberts AD, Simon GL. Diabetic foot infections: the role of microbiology and antibiotic treatment. Semin Vasc Surg. 2012;25(2):75-81.

Remy C, Ngba Essebe C, Sotto A, Lavigne JP. Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis. Toxins (Basel). 2016;8(7):209.

Bansal E, Garg A, Bhatia S, Attri AK, Chander J. Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol. 2008;51(2):204-8.